Top Markets
Coin of the day
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Peringkat dalam Saham #15973
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Harga Saham
$15.42
Kapitalisasi Pasar
$320.83M
Perubahan (1 hari)
-1.52%
Perubahan (1 tahun)
40.67%
Negara
IT
Perdagangan Newron Pharmaceuticals S.p.A. (NP5)

Kategori

Riwayat harga saham Newron Pharmaceuticals S.p.A. (NP5)
Harga penutupan tertinggi: $15.42 pada 2026-09-01

Harga penutupan terendah: $6.42 pada 2019-07-01
Riwayat harga saham Newron Pharmaceuticals S.p.A. dari 2019 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -24.46%
2025 190.90%
2024 71.92%
2023 246.71%
2022 -14.11%
2021 -28.37%
2020 -64.91%
2019 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$548.27 40.22%
US
$1.02K 43.73%
NL
$152.77 534.16%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH